middle.news
Vitrafy Advances Cryopreservation Tech and Expands US Footprint Post-IPO
5:29pm on Sunday 1st of June, 2025 AEST
•
Life Sciences
Read Story
Vitrafy Advances Cryopreservation Tech and Expands US Footprint Post-IPO
5:29pm on Sunday 1st of June, 2025 AEST
Key Points
Completed $35 million IPO in November 2024 to fund growth
Significant improvements in cryopreservation outcomes for salmon and bovine reproduction
Initiated US business development with key appointments and military blood platelet study
Development of next-gen Cryopreservation Device 2.0 and LifeChain software on track
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE